Identifying Network Perturbation in Cancer.

We present a computational framework, called DISCERN (DIfferential SparsE Regulatory Network), to identify informative topological changes in gene-regulator dependence networks inferred on the basis of mRNA expression datasets within distinct biological states. DISCERN takes two expression datasets...

Full description

Bibliographic Details
Main Authors: Maxim Grechkin, Benjamin A Logsdon, Andrew J Gentles, Su-In Lee
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2016-05-01
Series:PLoS Computational Biology
Online Access:http://europepmc.org/articles/PMC4856318?pdf=render
_version_ 1818007225729286144
author Maxim Grechkin
Benjamin A Logsdon
Andrew J Gentles
Su-In Lee
author_facet Maxim Grechkin
Benjamin A Logsdon
Andrew J Gentles
Su-In Lee
author_sort Maxim Grechkin
collection DOAJ
description We present a computational framework, called DISCERN (DIfferential SparsE Regulatory Network), to identify informative topological changes in gene-regulator dependence networks inferred on the basis of mRNA expression datasets within distinct biological states. DISCERN takes two expression datasets as input: an expression dataset of diseased tissues from patients with a disease of interest and another expression dataset from matching normal tissues. DISCERN estimates the extent to which each gene is perturbed-having distinct regulator connectivity in the inferred gene-regulator dependencies between the disease and normal conditions. This approach has distinct advantages over existing methods. First, DISCERN infers conditional dependencies between candidate regulators and genes, where conditional dependence relationships discriminate the evidence for direct interactions from indirect interactions more precisely than pairwise correlation. Second, DISCERN uses a new likelihood-based scoring function to alleviate concerns about accuracy of the specific edges inferred in a particular network. DISCERN identifies perturbed genes more accurately in synthetic data than existing methods to identify perturbed genes between distinct states. In expression datasets from patients with acute myeloid leukemia (AML), breast cancer and lung cancer, genes with high DISCERN scores in each cancer are enriched for known tumor drivers, genes associated with the biological processes known to be important in the disease, and genes associated with patient prognosis, in the respective cancer. Finally, we show that DISCERN can uncover potential mechanisms underlying network perturbation by explaining observed epigenomic activity patterns in cancer and normal tissue types more accurately than alternative methods, based on the available epigenomic data from the ENCODE project.
first_indexed 2024-04-14T05:12:58Z
format Article
id doaj.art-cb43c7c70f4c41fe8db0c3157da9debf
institution Directory Open Access Journal
issn 1553-734X
1553-7358
language English
last_indexed 2024-04-14T05:12:58Z
publishDate 2016-05-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS Computational Biology
spelling doaj.art-cb43c7c70f4c41fe8db0c3157da9debf2022-12-22T02:10:29ZengPublic Library of Science (PLoS)PLoS Computational Biology1553-734X1553-73582016-05-01125e100488810.1371/journal.pcbi.1004888Identifying Network Perturbation in Cancer.Maxim GrechkinBenjamin A LogsdonAndrew J GentlesSu-In LeeWe present a computational framework, called DISCERN (DIfferential SparsE Regulatory Network), to identify informative topological changes in gene-regulator dependence networks inferred on the basis of mRNA expression datasets within distinct biological states. DISCERN takes two expression datasets as input: an expression dataset of diseased tissues from patients with a disease of interest and another expression dataset from matching normal tissues. DISCERN estimates the extent to which each gene is perturbed-having distinct regulator connectivity in the inferred gene-regulator dependencies between the disease and normal conditions. This approach has distinct advantages over existing methods. First, DISCERN infers conditional dependencies between candidate regulators and genes, where conditional dependence relationships discriminate the evidence for direct interactions from indirect interactions more precisely than pairwise correlation. Second, DISCERN uses a new likelihood-based scoring function to alleviate concerns about accuracy of the specific edges inferred in a particular network. DISCERN identifies perturbed genes more accurately in synthetic data than existing methods to identify perturbed genes between distinct states. In expression datasets from patients with acute myeloid leukemia (AML), breast cancer and lung cancer, genes with high DISCERN scores in each cancer are enriched for known tumor drivers, genes associated with the biological processes known to be important in the disease, and genes associated with patient prognosis, in the respective cancer. Finally, we show that DISCERN can uncover potential mechanisms underlying network perturbation by explaining observed epigenomic activity patterns in cancer and normal tissue types more accurately than alternative methods, based on the available epigenomic data from the ENCODE project.http://europepmc.org/articles/PMC4856318?pdf=render
spellingShingle Maxim Grechkin
Benjamin A Logsdon
Andrew J Gentles
Su-In Lee
Identifying Network Perturbation in Cancer.
PLoS Computational Biology
title Identifying Network Perturbation in Cancer.
title_full Identifying Network Perturbation in Cancer.
title_fullStr Identifying Network Perturbation in Cancer.
title_full_unstemmed Identifying Network Perturbation in Cancer.
title_short Identifying Network Perturbation in Cancer.
title_sort identifying network perturbation in cancer
url http://europepmc.org/articles/PMC4856318?pdf=render
work_keys_str_mv AT maximgrechkin identifyingnetworkperturbationincancer
AT benjaminalogsdon identifyingnetworkperturbationincancer
AT andrewjgentles identifyingnetworkperturbationincancer
AT suinlee identifyingnetworkperturbationincancer